| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,218 |
17,230 |
$628K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
581 |
577 |
$281K |
| 94060 |
|
8,154 |
7,895 |
$219K |
| 94729 |
|
2,691 |
2,595 |
$95K |
| 94726 |
|
2,713 |
2,616 |
$90K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
354 |
259 |
$71K |
| 95811 |
|
132 |
131 |
$63K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
685 |
661 |
$54K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
553 |
167 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,407 |
1,319 |
$30K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,781 |
671 |
$25K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,644 |
1,629 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
889 |
760 |
$10K |
| 90756 |
|
521 |
500 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
558 |
530 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
123 |
104 |
$4K |
| 90674 |
|
431 |
378 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
622 |
619 |
$2K |
| 0011A |
|
149 |
136 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
495 |
438 |
$2K |
| 99406 |
|
231 |
204 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
178 |
81 |
$2K |
| 0012A |
|
72 |
69 |
$1K |
| 0013A |
|
94 |
91 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
27 |
25 |
$578.70 |
| 99318 |
|
45 |
44 |
$312.59 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
201 |
173 |
$277.03 |
| 90661 |
|
12 |
12 |
$195.51 |
| 0031A |
|
17 |
16 |
$144.79 |
| 99407 |
|
14 |
12 |
$109.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
165 |
147 |
$36.74 |
| 91301 |
|
356 |
330 |
$0.43 |
| 91303 |
|
16 |
16 |
$0.01 |
| 4004F |
|
185 |
168 |
$0.00 |
| 4040F |
|
2,517 |
2,319 |
$0.00 |
| G8842 |
Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea |
6,024 |
5,602 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
399 |
371 |
$0.00 |
| G9695 |
Long-acting inhaled bronchodilator prescribed |
2,583 |
2,254 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
6,084 |
5,422 |
$0.00 |
| G8845 |
Positive airway pressure therapy prescribed |
4,863 |
4,545 |
$0.00 |
| 3023F |
|
1,499 |
1,360 |
$0.00 |
| G8851 |
Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented) |
4,337 |
4,080 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
262 |
254 |
$0.00 |
| G8854 |
Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy) |
164 |
156 |
$0.00 |
| G8852 |
Positive airway pressure therapy was prescribed |
4,066 |
3,824 |
$0.00 |
| G8846 |
Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater) |
5,997 |
5,575 |
$0.00 |
| G8839 |
Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness |
4,879 |
4,559 |
$0.00 |
| G8924 |
Spirometry results documented (fev1/fvc < 70%) |
1,528 |
1,391 |
$0.00 |
| 1036F |
|
1,508 |
1,354 |
$0.00 |
| G8849 |
Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage) |
814 |
776 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
282 |
257 |
$0.00 |
| 99441 |
|
27 |
26 |
$0.00 |